Hada C. Macher

Prognostic and diagnostic value of eosinopenia, C-reactive protein, procalcitonin, and circulating cell-free DNA in critically ill patients admitted with suspicion of sepsis

José Garnacho‐Montero, María J Huici-Moreno, Isabel López et al. · Critical Care · 2014 · 148 citations · Full text

Role of early cell-free DNA levels decrease as a predictive marker of fatal outcome after severe traumatic brain injury

Hada C. Macher, J.J. Egea-Guerrero, J. Revuelto‐Rey et al. · Clinica Chimica Acta · 2012 · 90 citations

Traumatic Brain Injury, Fatal Outcome, Brain Injury +5

Monitoring of Transplanted Liver Health by Quantification of Organ-Specific Genomic Marker in Circulating DNA from Receptor

Hada C. Macher, G. Suárez Artacho, Juan M. Guerrero et al. · PLoS ONE · 2014 · 54 citations · Full text

Standardization non-invasive fetal RHD and SRY determination into clinical routine using a new multiplex RT-PCR assay for fetal cell-free DNA in pregnant women plasma: Results in clinical benefits and cost saving

Hada C. Macher, P. Noguerol, Pablo Medrano‐Campillo et al. · Clinica Chimica Acta · 2011 · 42 citations

Infertility, Clinical Routine, Medicine +9

Role of Circulating Cell-free DNA Levels in Patients With Severe Preeclampsia and HELLP Syndrome

María Luisa Miranda, Hada C. Macher, Rocío Múñoz‐Hernández et al. · American Journal of Hypertension · 2013 · 40 citations · Full text